The biotech will explore the potential of BI-1808 plus Keytruda in clear cell and high-grade serous ovarian cancer subtypes.

Immunonutritional status, assessed by PNI and SII, significantly influences ovarian cancer prognosis, affecting survival outcomes and chemotherapy tolerance. High PNI and low SII correlate with longer ...

Terri Baker was diagnosed with stage 4 ovarian cancer in September. Today, the cancer is undetectable. When Terri Baker walked into an emergency room for blood in her urine, doctors diagnosed her with ...

Researchers have developed a new prediction tool that could help clinicians better assess whether complete tumour removal is ...

ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each recommendation, following the guideline development process as outlined in the ASCO ...

Long-Term Follow-Up of Real-World Adjuvant Anti–PD-1 Checkpoint Inhibition and Targeted Therapy in Patients With Stage III Melanoma In this phase II, open-label study, patients with recurrent, ...

Ovarian cancer remains a significant challenge in women's health, with high mortality rates due to late-stage diagnosis. This webinar aims to provide healthcare professionals with an in-depth ...

Women with an inherited risk of developing ovarian cancer because they have the so-called Angelina Jolie gene alteration can now be tested on the NHS thanks to UCL research. University College London ...